I doubt BG will do anything at all. They’ve been at this a while and say themselves their Funds and Trusts are a 5 year hold minimum, they’ll have seen events like this plenty of times over the years.
Ark are different, they’re actively managing ETFs so they have to play that part. Personally I couldn’t believe they sold off so much in the wake of this but I reckon they’re feeling the pressure from such a massive loss on the tech sell-off. Like anyone would, when the pressure or losses start to compound, naturally you cave.
PDD rebounded 15% today. Most other big China names anywhere between 5-10%. Ark have made a mistake there.
BG are much more seasoned at this. 5 year hold it is.
I held PHI and actually sold out of it for profit after maybe half a year. I felt I was too spread out in my ITs holding Scottish Mortgage, BG China Growth and BG US Growth. I felt at the time and still do feel that Chinese companies will have a bright future and BGCG will rebound. Ultimately I trust the crew over at BGCG have done their homework.
Building long-term value is not about following the pack, but about spotting the companies set to benefit from social change, according to Scottish Mortgage’s managers. This short article provides an overview of this idea, and other topics discussed in a recent webinar with investment specialist Claire Shaw and Scottish Mortgage Managers James Anderson, Lawrence Burns and Tom Slater.
Hi, I’ve read recently in the economist that it’s possible that Chinese stocks could delist from US stock exchanges over the next 3 years. I’m not entirely clear on what this means because of all the different types of Chinese stocks available.
I’m long on China through BCBG and so wanted to check what types of stocks Baillie held in the IT. As per their portoflio doc most of the stocks are either US listed or KYG (Cayman Islands) which from what I understand means they’re exposed to being tampered with (aka delisted)?
Am I correct in my understanding?
If so is anyone else worried or am I being a bit too alarmist?
It’s not a massive holding for me (3% of total portfolio) so will keep it but was just doing some due diligence on my holdings.
Don’t think you’re being too alarmist, the current climate around Chinese stocks is not nice, but I’d maybe just take solace in the fund manager and trust in their abilities. If they have to come out of US or Cayman-based stocks, they do have the ability to invest directly in the Chinese market. I’m sure they’ll adapt accordingly.
Thanks for the feedback, @random53. I’m not personally interested in this company, but someone might find it interesting. For example, when I’ve listened to an interview with the SMT managers, I’ve found out similarly that a private company in the SMT fund would go public via spac (Ginkgo Bioworks) and immediately started a position.
No worries. Just wanted to share what I find. Personally i just like to see that some of the non-public investments are transitioning. Some big names in the portfolio.
I’ve never done well from investing at ipo so I leave it to specific funds now. SPACs have done well for me in the past but not so much recently. I expected more of a reaction when SOAC announced gingko…
These short reports are designed for one thing: to give the reporters a dump to ride. It’s not like they keep banging the drum once the landslide has occurred.
I’ll take BG’s analysis over some glorified bloggers any day of the week.
It’s laughably poor short report. References lots of staff and ex directors all that have left and have shockingly bad things to say - yet the anonymous public forum that is Glassdoor has the CEO score at 100% - almost unseen and the company score high 90’s - also rare.
The report they mention and quote from halfway through the report has a few areas where it believes the valuation is a bit sticky (we all do), but the vast majority of the crap they pull from it is counter argued in the very same report later on.
It’s a piss poor, copy and paste short report where they’ve just changed the names of the last target.
